Jazz Pharmaceuticals
JAZZ
#1515
Rank
C$20.21 B
Marketcap
C$311.34
Share price
-1.81%
Change (1 day)
64.18%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): C$1.01 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are C$4.60 Billion. In 2025 the company made an earning of -C$0.9 Billion a decrease over its 2024 earnings that were of C$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.01 B-213.27%
2025 -C$0.9 Billion-233.49%
2024 C$0.67 B57.87%
2023 C$0.42 B-179.92%
2022 -C$0.54 Billion230.37%
2021 -C$0.17 Billion-141.02%
2020 C$0.39 B-39.45%
2019 C$0.64 B-14.2%
2018 C$0.75 B20.03%
2017 C$0.62 B-17.15%
2016 C$0.75 B22.14%
2015 C$0.62 B187.64%
2014 C$0.21 B-50.79%
2013 C$0.43 B73.63%
2012 C$0.25 B41.69%
2011 C$0.17 B116.61%
2010 C$82.37 M262.77%
2009 C$22.7 M-111.33%
2008 -C$0.21 Billion1.31%
2007 -C$0.2 Billion77.8%
2006 -C$0.12 Billion36.59%
2005 -C$81.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.12 B 2,033.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
C$2.98 B 188.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-C$3.41 Billion-428.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
C$2.28 B 120.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel